Articles

This consent is given under sections 14 and 14A of the Therapeutic Goods Act 1989.

We've updated the Listed Medicine Compliance Reports database with the results of compliance reviews covering 7 listed medicines.

We have published new guidance to help journalists and news organisations understand when media reporting on therapeutic goods may be regulated as advertising.

New medicine labelling standards have been published to replace TGO 91 and TGO 92. Sponsors will have a 5-year transition period to update labels.

We have improved the way we present our Product Information (PI) safety updates to help you find the information you need.

We have started Federal Court proceedings against BioV8 (now in liquidation) and its former directors, alleging they breached the Therapeutic Goods Act 1989 by unlawfully advertising prescription-only therapeutic products, including peptides.

Andrographis paniculata (Andrographis) has been removed from the ingredients allowed in new listed medicines intended for supply in Australia from 17 September 2026.

We have issued two infringement notices totalling $39,600 to New South Wales-based company Suryam Energy Pty Ltd (Suryam Energy) for the alleged unlawful supply of vaping goods.

We have decided to remove Andrographis paniculata from the Permissible Ingredients Determination following an updated safety review and supplementary report and consideration of submissions received through a targeted consultation.

We have added our recent decisions to the list of Australian manufacturers licensed by the TGA.

Information for health professionals about medicines with safety related updates to their Product Information.

We have conducted a review and are proposing options for additional safeguards for 4-methylbenzylidene camphor (4-MBC), an active ingredient used in some Australian sunscreens.

The Australian Government has made changes to the Personal Importation Scheme, to help authorities identify imported therapeutic goods and reduce the risk of unidentified, mislabelled or counterfeit products entering Australia.

Updated classification rules for non-invasive medical devices that are used to maintain the patency or flush the lumen of another medical device.

We have amended the Clinical Decision Support System (CDSS) exemption to provide greater clarity about when the exemption applies. The amendments come into effect from 1 November 2026.

We have approved an updated indication for TRUQAP (capivasertib) following evaluation of additional clinical data submitted after the medicine's initial registration.

TGA has issued 10 infringement notices totalling $71,280 to Gezond Pty Ltd and 3 registered pharmacists.

The TGA, working with the NSW Police Force and other state and Commonwealth enforcement agencies, supported coordinated enforcement operations targeting a company allegedly involved in the importation, storage and distribution of vaping goods, nicotine pouches, illicit tobacco and other unlawful products.

TGA with the assistance of the NSW Police has seized more than $120,000 of illicit peptide and anabolic steroid products from 2 residential premises in New South Wales allegedly linked to a social media influencer.

The TGA is updating information for acceptable intake of nitrosamine impurities in medicines.

Two Victorian residents have been charged with additional offences following an Australian Border Force led investigation into the alleged importation of Performance and Image Enhancing Drugs into Australia.

We are seeking feedback on our proposal to improve information sharing about the safety, quality, and performance of medical devices.

The Therapeutic Goods Administration (TGA) is aware of media reports about the safety of defibrillator devices used in some ambulance services and healthcare facilities.

Information for health professionals about medicines with safety related updates to their Product Information.

As part of a coordinated enforcement action, 4 search warrants were simultaneously executed at 2 retail premises in Kippax, a retail premises in Belconnen, and a residence in north Canberra.